It has been found that the matrikine endostatin is increased in the lungs of patients with acute respiratory distress syndrome (ARDS), including COVID-19-related ARDS, and this increase promotes thrombin-induced epithelial barrier dysfunction and platelet and neutrophil activation [45]. Here, COL18A1 is linked to acute respiratory distress syndrome.